Inicio Base de datos de reclamaciones Transparency International Germany vs. Ratiopharm
Queja

Transparency International Germany vs. Ratiopharm

Ratiopharm’s unethical marketing in Germany, Belgium et al

Fecha de presentación
20 April 2006
Palabras clave
Países de daño
Situación actual
Rechazada
Sector
NCP

Acusaciones

Ratiopharm, a pharmaceuticals company and major producer of generic drugs, has allegedly engaged in unethical marketing practices, including bribing doctors and pharmacists in Belgium, Canada, Spain, Estonia and Germany.

Directrices relevantes de la OCDE

Resultado

In June 2006, the German NCP rejected the complaint citing the lack of transnational investment. Specifically, the NCP stated the complaint only dealt with alleged misbehaviour in Germany. In July 2006, Transparency International Germany resubmitted a revised and expanded complaint

Más detalles

Demandante
Empresa en infracción
Demandantes
Personas afectadas
Fecha rechazada / concluida
27 June 2006

Quejas relacionadas

Documentos

  • archivo
    18 July 2006

    TI submits revised and expanded complaint (see: Transparency International - Germany vs. Ratiopharm refile).

    Transparency International Germany
  • archivo
    20 April 2006

    Complaint submitted to German NCP.

    Transparency International Germany